Cure My Disease

Don't miss your cure!

 Log in / Sign up

Shockwave or ultrasound? trial aims to settle which therapy eases sciatica pain and improves sleep

NCT ID NCT07710924

Symptom relief Sponsor: University of Lahore Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 17, 2026 · Last updated Jul 17, 2026

Summary

This study compares two common treatments—shockwave therapy and therapeutic ultrasound—each given alongside standard physiotherapy, for people with chronic sciatica. The goal is to see which approach better reduces pain, improves hamstring flexibility, enhances sleep quality, and boosts overall quality of life. Adults aged 20 to 45 with persistent sciatica symptoms for at least three months are eligible to join.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Extracorporeal Shockwave Therapy (ESWT) and Therapeutic Ultrasound, each combined with conventional physiotherapy
What this could lead to
If shockwave therapy proves more effective than ultrasound, it could become a preferred non-invasive option for managing chronic sciatica pain and improving sleep and mobility.
What could go wrong
This is a small, single-center trial with 66 participants, so results may not apply broadly. Both treatments are already used, so the difference in benefit may be small or not clinically meaningful.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

66 people

The number who actually took part.

Started

Jun 2025

Finished

Apr 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 45 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 20-45 years. * Clinically diagnosed chronic sciatica. * Radiating pain below the knee. * Positive Straight Leg Raise test (30°-70°). * Pain intensity ≥4/10 on the Numeric Pain Rating Scale. * Symptoms persisting for at least 3 months. * Presence of tingling, numbness, lumbar radiculopathy, or piriformis syndrome. Exclusion Criteria: * Lumbar disc herniation. * Progressive neurological disorders. * Ankylosing spondylitis. * Paget disease. * Tuberculosis. * Malignancy. * Rheumatoid arthritis or other inflammatory disorders. * Previous spinal surgery or fracture. * Fever, unexplained weight loss, or systemic illness.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic sciatica are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

radiculopathy sciatica

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic sciatica Lumbar radiculopathy Sciatica

Contacts and locations

Locations

  • ULTH

    Lahore, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.